Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05132062 · ClinicalTrials.gov registry record
Mehran 2.0 Risk Score for Prediction of CA-AKI After PCI
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 14,616
- Enrollment target
NCT05132062: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT05132062 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 14,616 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05132062 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 14,616 participants
- Enrollment target
Study Summary
Consecutive patients having percutaneous coronary intervention (PCI) over a period of 9 years at a large tertiary care center with available creatinine measurements both before and within 48 hours after the procedure were included; patients on chronic dialysis were excluded. Patients treated between 2012 and 2017 comprised the derivation cohort (n=14,616) and those treated from 2018 to 2020 formed the validation cohort (n=5,606). The primary endpoint is contrast-associated acute kidney injury (CA-AKI, defined per Acute Kidney Injury Network \[AKIN\]). In addition, independent predictors of CA-AKI will be derived from multivariate logistic regression analysis. Model 1 will include only preprocedural variables, while Model 2 will also include procedural variables. A weighted integer score based on the effect estimate of each independent variable will be used to calculate the final risk score for each patient. Impact on 1-year mortality will be also evaluated.
Primary Outcome
Contrast-Associated Acute Kidney Injury was defined according to the AKIN as an increase by ≥50% or ≥0.3mg/dl within 48 hours after PCI compared to pre-PCI serum creatinine
Interventions
- PROCEDURE Percutaneous Coronary Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,616 participants |
| Start Date | 2012-01-01 |
| Est. Completion | 2021-09-01 |
What the finished NCT05132062 record still lists
NCT05132062 is an observational study that tracks outcomes without assigning an intervention. Its 14,616 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Percutaneous Coronary Intervention is the first listed.
NCT05132062 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05132062 about?
NCT05132062 is a clinical study titled "Mehran 2.0 Risk Score for Prediction of CA-AKI After PCI". Consecutive patients having percutaneous coronary intervention (PCI) over a period of 9 years at a large tertiary care center with available creatinine measurements both before and within 48 hours after the procedure were included; patients on chronic dialysis were excluded. Patients treated between...
What is the current status of trial NCT05132062?
This trial is currently completed. The enrollment target is 14,616 participants. The study started on 2012-01-01. Estimated completion is 2021-09-01.
What interventions are being tested in trial NCT05132062?
The interventions under investigation include: Percutaneous Coronary Intervention (PROCEDURE).
Who is sponsoring clinical trial NCT05132062?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05359016 · 14,600 participants · NA
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
- NCT06849869 · 14,820 participants · NA
Collaborative Care Model for Perinatal Wellness Support Services - Population-Level Equity-Centered Systems Change
- NCT05591066 · 14,400 participants · NA
The Patient and Family Centered I-PASS LISTEN Study: Language, Inclusion, Safety, and Teamwork for Equity Now
- NCT00857922 · 15,000 participants
Neurosciences Research Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI